Document:

Employment Agreement - William J. Thomas

 Exhibit 10.33 
 EMPLOYMENT AGREEMENT 
 This Employment Agreement, dated as of November 19, 2007 (this
“Agreement”), is between Orchid Cellmark Inc., a Delaware corporation (the “Company”), and Mr. William J. Thomas, who resides at the address listed at the bottom of this Agreement (“Employee”). This Agreement
is intended to confirm the understanding between the Company and Employee with respect to Employee’s future employment by the Company. In consideration of the mutual promises and covenants contained in this Agreement, and for other good and
valuable consideration, the receipt and sufficiency of which are hereby mutually acknowledged, the parties have agreed as follows: 
 1.
Employment. 
 (a) Title and Duties. Subject to the terms and conditions of this Agreement, the Company will employ Employee,
and Employee will be employed by the Company, as Vice President & General Counsel, reporting to the Chief Executive Officer, provided, that Employee’s reporting relationship may change from time to time at the sole discretion of
the Company. Employee will have the responsibilities, duties and authority commensurate with said positions. Employee will also perform such other services of an employment nature for the Company as may be assigned to Employee from time to time by
the Chief Executive Officer. 
 (b) Devotion to Duties. For so long as Employee is employed hereunder, Employee will devote
substantially all of Employee’s business time and energies to the business and affairs of the Company, provided, that nothing contained in this Section 1(b) will be deemed to prevent or limit Employee’s right to manage
Employee’s personal investments on Employee’s own personal time, including, without limitation, the right to make passive investments in the securities of (i) any entity which Employee does not control, directly or indirectly, and
which does not compete with the Company, or (ii) any publicly held entity so long as Employee’s aggregate direct and indirect interest does not exceed three percent (3%) of the issued and outstanding securities of any class of
securities of such publicly held entity. 
 2. Term of Employment. 
 (a) Term. Subject to the terms hereof, Employee’s employment hereunder will commence on November 19, 2007 (the “Commencement
Date”) and will continue until November 19, 2010 (the “Initial Term”); provided, that Employee’s employment hereunder will be automatically extended for additional consecutive periods of one (1) year (each, a
“Subsequent Term”) unless either Employee or the Company has given written notice to the other that such automatic extension will not occur (a “Non-Renewal Notice”), which notice must be given no less than three (3) months
prior to the end of the relevant Initial Term or Subsequent Term. The Initial Term and any Subsequent Terms are referred to herein as the “Term.” 
 (b) Termination. Notwithstanding anything else contained in this Agreement, Employee’s employment hereunder will terminate upon the earliest to occur of the following: 
 (i) Death. Employee’s death, which termination shall be effective immediately; 
 (ii) Termination by the Company. 
 (A) Written notice by the Company to Employee that Employee’s employment is being terminated as a result of Employee’s incapacity or inability to further perform Employee’s duties and responsibilities
as contemplated herein for ninety (90) days or more within any six (6) month period, or because Employee’s physical or mental health has become so impaired as to make it impossible or impractical for Employee to perform
Employee’s duties and responsibilities contemplated herein (it being understood that the determination of Employee’s physical or mental health will be determined by a medical expert appointed by mutual agreement between the Company and
Employee) (such condition hereafter referred to as the “Disability”), which termination shall be effective on the date of such notice; 

 (B) Written notice by the Company to Employee that Employee’s employment is being
terminated for Cause (as defined below), which termination shall be effective on the date of such notice; or 
 (C) Written
notice by the Company to Employee that Employee’s employment is being terminated without Cause, which termination shall be effective on the date of such notice; or 
 (iii) Termination by Employee. Written notice by Employee to the Company that Employee is terminating Employee’s employment for any reason, which termination shall be effective thirty (30) days after
the date of such notice; or 
 (iv) End of Term. Conclusion of the Term, provided that either the Company or Employee has given a
timely Non-Renewal Notice. 
 Notwithstanding anything in this Section 2(b), the Company may at any point terminate Employee’s
employment for Cause prior to the effective date of any other termination contemplated hereunder. 
 (c) Definition of
“Cause”. For purposes of this Agreement, “Cause” shall mean that Employee has (i) intentionally committed an act or omission that materially harms the Company; (ii) been grossly negligent in performance of
Employee’s duties to the Company; (iii) committed an act of moral turpitude; (iv) committed an act of fraud or material dishonesty in discharging Employee’s duties to the Company; (v) breached any material provision of this
Agreement or any other agreement between Employee and the Company, as all of the foregoing may be amended from time to time, that results in material harm to the Company; or (vi) breached any provision of any code of conduct or ethics policy in
effect at the Company, as all of the foregoing may be amended from time to time; provided, that in the case of subparagraph (ii) where such gross negligence and the effects of such gross negligence are capable of remedy by the Employee,
there shall be no Cause unless the Company provides Employee with written notice reasonably detailing the purported basis for the Cause and Employee fails to remedy the effects of such gross negligence within thirty (30) days after
Employee’s receipt of such notice. 
 (d) Definition of “Change of Control”. For purposes of this Agreement, a
“Change of Control” shall occur on the date that either of the following occurs: (i) any “Person” (as such term is used in Sections 13(d) and 14(d) of the Securities Exchange Act of 1934, as amended) becomes the
“Beneficial Owner” (as defined in Rule 13d-3 under said Act), directly or indirectly, of securities of the Company representing more than fifty percent (50%) of the total voting power represented by the Company’s then outstanding
voting securities (excluding for this purpose the Company or its affiliated entities or any employee benefit plan of the Company); or (ii) a merger or consolidation of the Company whether or not approved by the Board, other than a merger or
consolidation which would result in the voting securities of the Company outstanding immediately prior thereto continuing to represent (either by remaining outstanding or by being converted into voting securities of the surviving entity or the
parent of such corporation) at least fifty percent (50%) of the total voting power represented by the voting securities of the Company or such surviving entity or parent of such corporation outstanding immediately after such merger or
consolidation, or the consummation of an agreement for the sale or disposition of the Company of all or substantially all of the Company’s assets. “Substantially all of the Company’s assets” shall be deemed to include the assets
of all business units and/or divisions of the Company and all of its affiliated entities. In all respects, the definition of “Change of Control” shall be interpreted to comply with Section 409A of the Internal Revenue Code of 1986, as
amended, and any successor statute, regulation and guidance thereto. 
 3. Compensation. 
 (a) Base Salary. While Employee is employed hereunder, the Company will pay Employee a base salary at the gross annual rate of $245,000 (the
“Base Salary”). The Chief Executive Officer shall review Employee’s Base Salary on at least an annual basis, with the first such review to be conducted in April 2008, and the Base Salary may be adjusted at the sole discretion of the
Chief Executive Officer or the Board of Directors (the “Board”) or its designee. The Base Salary will be payable in accordance with the Company’s payroll practices as in effect from time to time. The Company will deduct from each such
installment any amounts required by law to be deducted for employment related taxes and the like. 

 (b) Accelerated Start Bonus. 
 (i) Payment: Employee will be eligible to receive a bonus in the amount of $10,000, which will be paid in one lump sum, less employment related
taxes and withholdings, within 45 days of the Commencement Date hereunder. 
 (ii) Repayment to the Company Upon Termination: If
Employee’s employment with the Company terminates for any reason on or before May 19, 2008, Employee shall return the full amount of the bonus paid pursuant to Section 3(b)(i) to the Company. If Employee’s employment with the
Company terminates for any reason on or before November 19, 2008, Employee shall return fifty percent (50%) of the bonus paid pursuant to Section 3(b)(i) to the Company. Employee authorizes the Company to deduct, at the time of
Employee’s termination, the appropriate amount from all amounts then owed to Employee and agrees that such deductions are valid set-offs or other authorized deductions pursuant to any state or federal wage statute, and Employee agrees that if
such amounts owed to him are insufficient to satisfy the amount Employee owes to the Company, Employee will pay the Company the difference from Employee’s personal funds within thirty (30) days of Employee’s termination. Employee also
acknowledges and agrees that should he fail to make timely payment pursuant to this Section 3(b)(ii), and should the Company decide to litigate to enforce this provision due to his failure, Employee will pay the costs and attorneys’ fees
incurred by the Company in doing so. 
 (c) Annual Bonus. Employee will also be eligible to receive an annual performance bonus in
accordance with the Orchid Cellmark Inc. Incentive Bonus Plan (or, if applicable, any successor plan). The award and amount of any annual performance bonus shall be determined by the Chief Executive Officer and the Compensation Committee of the
Board (or its designee) and shall be primarily based on Employee’s performance and the overall performance of the Company, measured against goals that are approved by the Chief Executive Officer and the Compensation Committee. For 2007 the
Employee’s goals will be based on the 2007 Annual Company goals and, in particular, those goals pertaining to the Legal Department including Intellectual Property and business maintenance and development activities. The bonus target for each
year will be twenty-five percent (25%) of Employee’s Base Salary in effect at the end of the calendar year to which it relates, and the amount of any annual performance bonus for 2007 shall be pro-rated based on the number of calendar days
in 2007 during which the Company employs Employee as an Employee. For 2008 and subsequent years, the Employee shall submit proposed performance goals to be reviewed and approved by the Chief Executive Officer and the Compensation Committee of the
Board in their sole discretion, no later than March 31 of the year to which the goals relate. 
 (d) Equity Compensation.

 (i) Stock Options. The Company will grant to Employee non-qualified stock options to purchase Seventy-Five Thousand
(75,000) shares of the common stock of the Company at an exercise price equal to the fair market value of such stock at the close of market on November 16, 2007 (the “Grant Date”), which options will vest monthly in forty-eight
(48) equal installments over the four (4) years following the Grant Date and, except as otherwise provided in this Agreement, subject to such other terms and conditions as set forth in the Company’s standard form of option agreement.

 (ii) Effect of Change of Control. Notwithstanding anything herein to the contrary, in the event of a Change of Control, all stock
options held by Employee which have not previously vested shall vest and become fully exercisable upon the Change of Control. 
 (iii)
Stock Plan. The grant contemplated by 3(d)(i) shall be subject in all respects to the terms and conditions of the Orchid BioSciences, Inc. 2005 Amended and Restated Stock Plan or such other plan as may be in effect at the time of grant.

 (e) Fringe Benefits. Employee shall be entitled to participate in all employee benefit, welfare and other plans, practices, policies
and programs and fringe benefits of the Company on a basis no less favorable than those provided to other similarly situated executives of the Company at the Vice President level. 

 (f) Vacation. Employee will be entitled to accrue up to twenty (20) vacation days and five
(5) sick days per calendar year that Employee remains employed by the Company, subject to the terms of the 
 Company’s vacation and
sick leave policies, as they may be amended from time to time. All vacation days will be taken at times mutually agreed upon by Employee and the Company and will be subject to the business needs of the Company. 
 (g) Reimbursement of Expenses. The Company will reimburse Employee for all ordinary and reasonable documented out-of-pocket business expenses that
are incurred by Employee in furtherance of the Company’s business in accordance with the Company’s policies with respect thereto as in effect from time to time. 
 4. Severance Compensation. 
 (a) Definition of Accrued Obligations. For purposes of this
Agreement, “Accrued Obligations” means (i) the portion of Employee’s Base Salary that has accrued prior to any termination of Employee’s employment with the Company and has not yet been paid; (ii) an amount equal to the
value of Employee’s accrued unused vacation days; and (iii) the amount of any reasonable documented out-of-pocket expenses properly incurred by Employee on behalf of the Company prior to any such termination and not yet reimbursed.

 (b) Termination due to Death or Disability. If Employee’s employment hereunder is terminated due to Employee’s death or
Disability, the Company will pay the Accrued Obligations to Employee’s estate promptly following the effective date of such termination. 
 (c) Termination for Cause, or at the Conclusion of the Term. If Employee’s employment hereunder is terminated by the Company for Cause, or if Employee’s employment terminates as a result of the expiration of the Term, the
Company will pay the Accrued Obligations to Employee promptly following the effective date of such termination and shall have no further obligations to Employee. 
 (d) Termination without Cause. If Employee’s employment hereunder is terminated by the Company without Cause, then: 
 (i) The Company will pay the Accrued Obligations to Employee promptly following the effective date of such termination; 
 (ii) The Company will pay Employee an amount equal to six (6) months of his Base Salary in effect as of the effective date of such termination, which amount will paid, at the Company’s sole discretion
(i) in accordance with the Company’s usual payroll practices, (ii) in a lump sum payment, or (iii) no more than four (4) lump sum payments, provided that payment(s) hereunder shall begin no later than one (1) month
following the effective date of the termination and the entire amount shall be paid within six (6) months of the effective date of such termination. 
 (e) Effect of Termination On Equity. In the event of termination of Employee’s employment, all options shall terminate in accordance with the terms of Employee’s option agreements in effect at the
time of such termination. 
 (f) Release of Claims. The Company shall not be obligated to pay Employee any of the payments set forth in
Section 4 unless and until Employee has executed a timely separation agreement containing a general release in favor of the Company, and the agreement has by its terms become effective. 
 (g) No Other Payments or Benefits Owing. The payments and benefits set forth in this Section 4 shall be the sole amounts owing to Employee
upon termination of Employee’s employment for any reason. Employee shall not be eligible for any other payments, including but not limited to additional Base Salary payments, bonuses, commissions, or other forms of compensation or benefits. The
compensation and benefits set forth in this Section shall be the sole remedy, if any, available to the Employee in the event that he brings any claim against the Company for any claims arising from or relating to the termination of his employment
under this Agreement. 

 5.6. Property and Records. Upon termination of Employee’s employment hereunder for any reason
or for no reason, Employee will promptly deliver to the Company any property of the Company which may be in Employee’s possession, including blackberry-type devices, laptops, cell phones, products, materials, memoranda, notes, records, reports
or other documents or photocopies of the same. 
 7. General. 
 (a) Notices. Except as otherwise specifically provided herein, any notice required or permitted by this Agreement shall be in writing and shall be
delivered as follows with notice deemed given as indicated: (i) by personal delivery when delivered personally; (ii) by overnight courier upon written verification of receipt; (iii) by telecopy or facsimile transmission upon
acknowledgment of receipt of electronic transmission; or (iv) by certified or registered mail, return receipt requested, upon verification of receipt. Notices to Employee shall be sent to the last known address in the Company’s records or
such other address as Employee may specify in writing. Notices to the Company shall be sent to the Company’s Chief Executive Officer or to such other Company representative as the Company may specify in writing. 
 (b) Entire Agreement. This Agreement, together with any other agreements specifically referred to herein, embodies the entire agreement and
understanding between the parties hereto with respect to the subject matter hereof and supersedes all prior oral or written agreements and understandings relating to the subject matter hereof. No statement, representation, warranty, covenant or
agreement of any kind not expressly set forth in this Agreement will affect, or be used to interpret, change or restrict, the express terms and provisions of this Agreement. 
 (c) Modifications and Amendments. The terms and provisions of this Agreement may be modified or amended only by written agreement executed by the
parties hereto. 
 (d) Waivers and Consents. The terms and provisions of this Agreement may be waived, or consent for the departure
therefrom granted, only by written document executed by the party entitled to the benefits of such terms or provisions. No such waiver or consent will be deemed to be or will constitute a waiver or consent with respect to any other terms or
provisions of this Agreement, whether or not similar. Each such waiver or consent will be effective only in the specific instance and for the purpose for which it was given, and will not constitute a continuing waiver or consent. 
 (e) Assignment. The Company may assign its rights and obligations hereunder to any person or entity that succeeds to all or substantially all of
the Company’s business or that aspect of the Company’s business in which Employee is principally involved. Employee may not assign Employee’s rights and obligations under this Agreement without the prior written consent of the
Company. 
 (f) Governing Law. This Agreement and the rights and obligations of the parties hereunder will be construed in accordance
with and governed by the law of the State of New Jersey. 
 (g) Arbitration. Any dispute arising out of this Agreement shall be
resolved through final and binding arbitration. The arbitration shall be conducted under the auspices of the American Arbitration Association (“AAA”) in accordance with the rules and procedures of AAA then in effect. The arbitration shall
take place in the State of New Jersey and shall be heard and decided by a single arbitrator. The decision and award of the arbitrator shall be final and binding. The prevailing party in any such arbitration shall be entitled to recover its
reasonable costs and attorney’s fees incurred in connection with the arbitration. 
 (h) Severability. The parties intend this
Agreement to be enforced as written. However, should any provisions of this Agreement be held by a court of law to be illegal, invalid or unenforceable, the legality, validity and enforceability of the remaining provisions of this Agreement shall
not be affected or impaired thereby. 
 (i) Headings and Captions. The headings and captions of the various subdivisions of this
Agreement are for convenience of reference only and will in no way modify or affect the meaning or construction of any of the terms or provisions hereof. 

 8. Taxation. Except as specifically set forth in this Agreement, the Company does not guarantee
the tax treatment or tax consequences associated with any payment or benefit arising under this Agreement, including but not limited to consequences related to Section 409A of the Internal Revenue Code, as amended. The Company and Employee
agree that both will negotiate in good faith and jointly execute an amendment to modify this Agreement to the extent necessary to comply with the requirements of Code Section 409A, or any successor statute, regulation and guidance thereto;
provided, that no such amendment shall increase the total financial obligation of the Company under this Agreement. 
 9.
Counterparts. This Agreement may be executed in two or more counterparts, and by different parties hereto on separate counterparts, each of which will be deemed an original, but all of which together will constitute one and the same
instrument. For all purposes a signature by fax shall be treated as an original. 
 REMAINDER OF PAGE INTENTIONALLY LEFT BLANK

 IN WITNESS WHEREOF, the parties hereto have executed this Agreement as of the date first written above. 
  

									
	William J. Thomas	 		 	ORCHID CELLMARK INC.
				
	/s/ William J. Thomas	 		 	By:	 	/s/ Thomas A. Bologna
	 Signature
 Address:
	 		 	 Name: Thomas A. Bologna
 Title:
President & CEOEmployment Agreement

 EXHIBIT 10.45 
 EMPLOYMENT AGREEMENT 
 THIS AGREEMENT (“Agreement”) dated as of
March 10, 2008 is entered into by and between MSC-Medical Services Company, a Florida corporation (the “Company”), and Robert DiProva (“Executive”). 
 Recitals 
 The Company, through its Board of Directors (the “Board”),
desires to retain the services of Executive, and Executive desires to be retained by the Company, on the terms and conditions set forth in this Agreement. This Agreement replaces and supersedes the Employment Agreement dated February 28, 2008,
which the parties hereby agree is null and void. 
 Agreement 
 For and in consideration of the foregoing and the mutual covenants of the parties herein contained, and for other good and valuable consideration, the
receipt and sufficiency of which are hereby acknowledged, the parties agree as follows: 
 1. EMPLOYMENT. The Company hereby employs
Executive to serve in the capacities described herein, and Executive hereby accepts such employment and agrees to perform the services described herein upon the terms and conditions hereinafter set forth. 
 2. TERM. The employment of Executive under this Agreement shall be for a period of three (3) years beginning on March 17, 2008 (the
“Effective Date”) and ending on March 16, 2011 (the “Initial Term”). Thereafter, this Agreement shall automatically renew for successive one (1) year periods, unless either party provides written notice to the other
party of its intention to terminate this Agreement thirty (30) days prior to the expiration of the term (each a “Renewal Term” and together with the Initial Term, the “Term”). The Term shall be subject to earlier termination
in accordance with the terms and conditions of this Agreement. 
 3. DUTIES. For the period from March 17, 2008 through
March 31, 2008, Executive shall serve as and have the title of Senior Vice President of Finance and shall have such duties as assigned by the Chief Executive Office of the Company from time to time. Beginning on April 1, 2008 and
continuing thereafter, Executive shall serve as and have the title of Senior Vice President and Chief Financial Officer and shall have such duties as assigned by the Chief Executive Officer of the Company from time to time. Executive agrees to
devote his full business time, energy, skills and best efforts to such employment while so employed. Executive and the Company acknowledge and agree that Executive shall relocate his primary residence to the Jacksonville, Florida area by the end of
the Temporary Period (as defined below). Notwithstanding the foregoing, Executive acknowledges that he shall be required to fulfill his duties on a full-time basis at the Company’s principal place of business during the Temporary Period.
Nothing in this Agreement shall preclude Executive from engaging in charitable and community affairs so long as, in the reasonable determination of the Board, such activities do not interfere with his duties and responsibilities hereunder or from
serving, subject to the prior approval of the Board, as a member of the board of directors or as a trustee of any other corporation, association or entity. 

 4. COMPENSATION. 
 (a) Base Compensation. The Company shall pay Executive, and Executive agrees to accept, an initial base compensation at the initial rate of Two Hundred Sixty Five Thousand Dollars ($265,000) per year, in equal
installments no less frequently than monthly, through the Term (the “Base Compensation”). The Base Compensation shall be reviewed by the Company annually and subject to adjustment according to the performance of the Executive, as
determined by the Board, in its sole and absolute discretion. 
 (b) Annual Bonus Compensation. Each calendar year, Executive shall be
eligible to participate in the Company’s executive performance bonus plan, which shall provide for an annual bonus based on the realization of financial and performance goals of the Company and the Executive (and Executive’s target bonus
under such plan shall be equal to 40% of his Base Compensation, with a maximum payout of up to 60% of his Base Compensation). For calendar year 2008, Executive shall be guaranteed a bonus of at least $35,000, which such bonus shall be payable in
February 2009. 
 (c) Stock Options. Executive shall be entitled to receive, pursuant to a separate Non-Statutory Stock Option
Agreement, options to purchase One Million Nine Hundred Sixty Seven Thousand Forty Nine (1,967,049) shares of common stock of MCP-MSC Acquisition, Inc., a Delaware corporation and the sole shareholder of the Company (the “Parent”).

 5. BENEFITS. 
 (a)
Generally. Executive shall be eligible for fringe benefits pursuant to any pension, retirement, or other employee fringe benefit plan that the Company makes available to employees of the Company and for which Executive will qualify according
to his eligibility under the provisions thereof, on the same basis as is applicable to other similarly situated executive employees. 
 (b)
Health and Disability Insurance. Executive, and all members of the Executive’s immediate family, shall be entitled to participate in health and disability insurance plans that the Company offers to other employees of the Company from
time to time, on the same basis as is applicable to other similarly situated executive employees, consistent with past practice. 
 (c)
Vacation. During the Term of this Agreement, Executive shall be entitled to twenty (20) paid vacation days, plus paid Company holidays and sick days in accordance with the Company’s policies and procedures applicable to similarly
situated executive employees. 
 6. EXPENSES. Except as otherwise agreed to herein, Executive shall be reimbursed for all usual
business expenses incurred on behalf of the Company, in accordance with Company practices and procedures. Additionally, the Executive shall have up to Fifty Thousand Dollars ($50,000) (the “Relocation Allowance”) to use, in his discretion,
in connection with: (a) the actual, reasonable costs and expenses incurred in connection with Executive’s temporary residence in Jacksonville, Florida for a period of up to ninety (90) 

 
days following the Effective Date (the “Transition Period”); (b) the actual, reasonable travel costs of the Executive to return to his primary
residence during the Transition Period; and (c) all actual out-of-pocket relocation expenses incurred by Executive in connection with his relocation to Jacksonville, Florida (including, the closing costs incurred with respect to the sale and
purchase of his primary residence) within nine months of the Effective Date (the “Temporary Period”); provided, however, that Executive shall only be permitted to utilize $25,000 of the Relocation Allowance for costs and expenses relating
to (a) and (b) above. 
 7. TERMINATION. The term of Executive’s employment under this Agreement may be terminated
prior to expiration of the Term provided in Section 2 hereof only in accordance with the following sections. 
 (a) For Cause.
This Agreement may be immediately terminated by the Company for Cause. For purposes of this Agreement, the term “Cause” shall include, without limitation, the termination of Executive by the Company as a result of the existence or
occurrence of one or more of the following conditions or events: 
 (i) the failure of Executive to follow any reasonable and
lawful directive of the Company, which failure continues after the date which is ten (10) days after the Company provides the Executive with written notice of such failure; 
 (ii) the failure of Executive to perform his duties hereunder, which failure continues after the date which is ten (10) days after
the Company provides the Executive with written notice of such failure; 
 (iii) the breach of any provision hereof, which
breach is not cured within ten (10) days after written notice thereof to Executive; 
 (iv) Executive’s willful
misconduct in connection with the performance of his duties as an employee or officer of the Company; 
 (v) commission by
Executive of any act of fraud or material misrepresentation or a material act of misappropriation in connection with his duties as an employee or officer of the Company; 
 (vi) commission by Executive of any crime which constitutes a felony; 
 (vii) the entry of a judgment or order enjoining or preventing Executive from such activities as are material or essential for Executive
to perform his services as required by this Agreement; or 
 (viii) willful and deliberate conduct or activities by Executive
which would be reasonably likely to result in material damage to the business of the Company. 
 (b) Mutual. Executive’s
employment under this Agreement may be terminated upon mutual written agreement of the Company and Executive. 

 (c) Without Cause. The Company and the Executive shall have the right to terminate this Agreement
and the Executive’s employment with the Company at any time without Cause. 
 (d) Death. In the event of the death of Executive,
the employment of Executive shall terminate immediately. 
 (e) Disability. If, during Executive’s employment with the Company,
Executive shall become permanently disabled and unable to perform his duties as required herein (“Disability”) for a total of one hundred eighty (180) days in any twelve (12) month period then the Company may, upon thirty
(30) days written notice to Executive, terminate Executive’s employment under this Agreement. 
 (f) Constructive Discharge.
Executive may terminate this Agreement in the event of Constructive Discharge (as defined below) by providing written notice to the Company within three months after the occurrence of such event, specifying the event relied upon for a Constructive
Discharge; provided that such event is not cured within ten (10) days after written notice thereof to the Company. “Constructive Discharge” shall mean any (i) material change by the Company of Executive’s position,
functions, or duties to an inferior position, functions, or duties from those in effect on the Effective Date, (ii) assignment, reassignment, or relocation by the Company of Executive, without Executive’s consent, to another place of
employment more than 25 miles from the current principal place of business of the Company; (iii) reduction in Executive’s Base Compensation or the maximum potential amount of the Annual Bonus Compensation, or (iv) Change in Control
(as defined below). For purposes of this Section 7(f), Change in Control shall mean: 
  

	 	(A)	any change in the ownership of the capital stock of the Company if, immediately after giving effect thereto, any person (or group of persons acting in concert) other than Monitor
Clipper Equity Partners II, L.P. and Monitor Clipper Equity Partners II (NQP), L.P. (together with Monitor Clipper Equity Partners II, L.P., “MCP”) and their affiliates will have the direct or indirect power to elect a majority of the
members of the Board of Directors of the Company; 

  

	 	(B)	any sale or other disposition of all or substantially all of the assets of the Company (including without limitation through the sale of all or substantially all of the stock or
other equity interests of its direct or indirect subsidiaries or sale of all or substantially all of the assets of the Company and its direct or indirect subsidiaries, taken as a whole) to another person; 

  

	 	(C)	any merger or consolidation with another person (the “Change of Control Transferee”) if, immediately after giving effect thereto, any person (or group of persons acting in
concert) other than the Company and its affiliates will have the power to elect a majority of the members of the board of directors (or other similar governing body) of the Change of Control Transferee; or 

	 	(D)	any change in the ownership of the capital stock of the Parent or any issuance of shares of such capital stock or options, warrants or convertible securities with respect to such
capital stock if, immediately after giving effect thereto, MCP and its affiliates cease to own, directly or indirectly, at least 33 1/3% of the fully-diluted shares of the capital stock of the Parent. 

 Notwithstanding the foregoing, a Change of Control shall be deemed not to have occurred if, following any transaction or series of transactions, whether or not described
above, (i) MCP continues to hold an equity interest in a line of business of the Company (whether through the Company or another person or entity), (ii) MCP and its affiliates have the direct or indirect power to elect a majority of the
members of the Board (or similar governing body) of the Company (or such other person or entity), (iii) MCP and its affiliates own, directly or indirectly, at least 33 1/3% of the fully-diluted shares of the capital stock of the Parent of the
Company (or equity interests in such other person or entity) and (iv) Executive is offered continued employment as Senior Vice President and Chief Financial Officer of the Company (or such other person or entity) on the terms and conditions
contained herein. 
 8. SEVERANCE. In the event of the termination of Executive’s employment under this Agreement for any reason,
the Company shall provide the payments and benefits to Executive as indicated below: 
 (a) With Cause or Voluntary Termination by
Executive. If Executive is terminated for Cause (as defined in Section 7(a) of this Agreement), or if Executive voluntarily terminates his employment with the Company, the Company shall be obligated only to continue to pay to Executive his
Base Compensation, if any, earned up to the date of termination and shall reimburse Executive for any expenses to which Executive is due reimbursement by the Company under Section 6 hereof up until the date of termination. 
 (b) Without Cause, Constructive Discharge, Death or Disability. In the event that the Company shall terminate Executive without Cause, the
Executive shall terminate this Agreement for Constructive Discharge, or upon the death or Disability of Executive, (i) the Company shall be obligated to continue to pay full Base Compensation to Executive for a period of six (6) months
after the date of termination as if Executive had not been so terminated, and (ii) on the final date of payment of the Base Compensation under subsection (i), the Company shall pay Executive a lump sum amount equal to fifty percent
(50%) of the target amount of his annual bonus. 
 9. NONCOMPETITION; NONSOLICITATION. For a period beginning on the date hereof
and ending two (2) years following the date on which the Executive ceases to be employed by the Company, the Executive shall not, except as an employee or agent of the Company, engage or have an interest, anywhere in the United States of
America or any other geographic area where the Company did business as of the date hereof or at any time during the Executive’s employment by the Company or in which its products or services are or were marketed or sold, alone or in association
with others, as principal, agent, partner, stockholder, or through the investment of capital, lending of money or property, rendering of services or otherwise, in any business competitive with that engaged in by the Company as of the date hereof or
by the Company at any time during Executive’s employment by the Company 

 
(“Competitive Business”). For a period beginning on the date hereof and ending two years following the date on which the Executive ceases to be
employed by the Company, the Executive shall not, except as an employee or agent of the Company, directly or indirectly, on behalf of himself or any other person or entity, (A) accept business from or solicit the business of (in either case,
which such business is competitive with that of the Company) (a) any person or entity who is, or who had been at any time during the preceding two years or at any time during the Executive’s employment by the Company, a customer of the
Company or any successor to the business of the Company (each a “Customer”), or otherwise divert or attempt to divert any business from the Company or any successor or otherwise induce, request, advise or persuade any Customer to cease to
do business with or reduce the amount of business which such Customer has customarily done or is reasonably expected to do with the Company or any successor; or (B) solicit or induce any person who is an employee of, or otherwise engaged by,
the Company, to leave the employ or engagement of the Company or hire any such person until one (1) year after such person has left the employ of the Company, or any such successor or any person with whom such person was placed for employment
or engagement during the preceding one year. The Executive shall not at any time, directly or indirectly, except as an employee or agent of the Company, use or purport to authorize any person or entity to use any name, mark, logo, trade dress or
other identifying words or images which are the same as or similar to those used currently or in the past by the Company in connection with any product or service, whether or not such use would be in a business competitive with that of the Company.
Notwithstanding anything to the contrary contained herein, the following activities shall not be deemed to be a violation of the provisions of this Section: the ownership or control by the Executive of up to five percent of the outstanding voting
securities or securities of any class of a company with a class of securities which are publicly traded. 
 10. CONFIDENTIALITY. The
Executive acknowledges that the intellectual property and all other confidential or proprietary information with respect to the Company’s engagement in the business of distributing medical supplies and equipment, pharmaceuticals and services
throughout the United States of America (the “Business”) are valuable, special and unique. The Executive shall not, at any time after the date hereof, except as an employee or agent of the Company, or except as required by applicable law,
disclose, directly or indirectly, to any person or entity, or use or purport to authorize any person or entity to use any confidential or proprietary information with respect to the Company or the Business, whether or not for his own benefit,
without the prior written consent of the Company, including without limitation, confidential or proprietary information as to the financial condition, results of operations, strategic partners, customers, suppliers, products, products under
development, services, inventions, sources, leads or methods of obtaining new products or business, intellectual property, pricing methods or formulas, cost of supplies, marketing strategies or any other information relating to the Company or the
Business, but not including information which is or shall become generally available to the public or is generally known in the industry other than as a result of an unauthorized disclosure by the Executive or a person or entity to whom the
Executive has provided such information. The Executive acknowledges that Company would not enter into this Employment Agreement without the assurance that all such confidential and/or proprietary information will be used for the exclusive benefit of
the Company. 

 11. NONDISPARAGEMENT. Neither the Executive nor the Company shall (and shall cause the officers,
directors, employees, shareholders, members, partners, representatives and agents of any entity or business directly or indirectly controlled by the Executive and the Company to not) commit any act or omission that would tend to disparage or
adversely affect the reputation of the other party or any present or future subsidiaries, parents or affiliates of the other party or any of their respective principals, officers, directors, shareholders, members, employees, businesses or
operations. Without in any way limiting the generality of the foregoing, the Executive and the Company shall not (and shall cause the officers, directors, employees, shareholders, members, partners, representatives and agents of any entity or
business directly or indirectly controlled by the Executive and the Company to not) make any disparaging or unfavorable statements to any third party, either orally or in writing, regarding the other party or any present or future subsidiaries,
parents or affiliates of the other party or any of their respective principals, officers, directors, shareholders, members, employees, businesses or operations. 
 12. ENFORCEABILITY OF RESTRICTIVE COVENANTS. The restrictions set forth in this Agreement are considered by the parties hereto to be reasonable for the purposes of protecting the value of the business and
goodwill of the Company and the Business. The parties acknowledge that the Company would be irreparably harmed and that monetary damages would not provide an adequate remedy to the Company in the event the covenants contained in this Agreement were
not complied with in accordance with their terms. Accordingly, the Executive agrees that any breach or threatened breach by him of any provision of this Agreement shall entitle the Company to injunctive and other equitable relief to secure the
enforcement of these provisions, in addition to any other remedies which may be available to them, and that they shall be entitled to receive from the Executive reimbursement for all attorneys’ fees and expenses incurred by the Company in
enforcing these provisions. In addition to its other rights and remedies, the Company shall have the right to require the Executive, if he breaches any of the covenants contained in this Agreement to account for and pay over to the Company all
compensation, profits, money, accruals and other benefits derived or received, directly or indirectly, by such party from the action constituting such breach. If the Executive breaches the restrictive covenants set forth in this Agreement, the
running of the time periods described therein shall be tolled for so long as such breach continues. It is the desire and intent of the parties that the provisions of this Agreement be enforced to the fullest extent permissible under the laws and
public policies of each jurisdiction in which enforcement is sought. If any provisions of this Agreement relating to the time period, scope of activities or geographic area of restrictions is declared by a court of competent jurisdiction to exceed
the maximum permissible time period, such time period, scope of activities and/or geographic area, as the case may be, shall be reduced to the maximum that such court deems enforceable. If any provisions of this Agreement other than those described
in the preceding sentence are adjudicated to be invalid or unenforceable, the invalid or unenforceable provisions shall be deemed amended (with respect only to the jurisdiction in which such adjudication is made) in such manner as to render them
enforceable and to effectuate as nearly as possible the original intentions and agreement of the parties. For purposes of Sections 9 through 12 (inclusive), the definition of the term “Company” shall be deemed to include the Company and
all of its affiliates and subsidiaries. 

 13. NOTICES. Any notice required or permitted to be given under this Agreement shall be sufficient
if in writing and shall be effective when received if sent, postage-prepaid, by certified or registered mail, return receipt requested, or by overnight delivery service against receipt, to the addresses below or to such other address as either party
shall designate by written notice to the other: 
 If to Executive, to the address set forth below his name on the signature page hereto.

 If to the Company: 
 MSC-Medical Services Company 
 841 Prudential Drive, Ste. 900 
 Jacksonville, FL 32207 
 Attn: Chief Executive
Officer 
 with a copy to: 
 MSC-Medical Services Company 
 c/o Monitor Clipper Partners, LLC 
 Two Canal Park 
 Cambridge, MA 02141

 Attn: Adam Doctoroff 
 14.
ENTIRE AGREEMENT; MODIFICATION. 
 (a) This Agreement contains the entire agreement of the Company and Executive, and the Company and
Executive hereby acknowledge and agree that this Agreement supersedes any prior statements, writings, promises, understandings or commitments between the parties hereof. 
 (b) No future oral statements, promises or commitments with respect to the subject matter hereof, or other purported modification hereof, shall be binding upon the parties hereto unless the same is reduced to writing
and signed by each party hereto. 
 15. ASSIGNMENT. The rights and obligations of the parties under this Agreement shall inure to the
benefit of and shall be binding upon, and enforceable by, the successors and permitted assigns of the parties. Notwithstanding anything contained herein to the contrary, the Company shall have the right to assign this Agreement to any of its
subsidiaries, direct or indirect parents or other affiliates. Except as otherwise set forth in this Agreement, neither party may assign his or its rights or obligations under this Agreement without the prior written consent of the other party.

 16. GOVERNING LAW; VENUE; INDEPENDENT REPRESENTATION. This Agreement shall be governed by and construed in accordance with the
domestic laws of the State of Florida without giving effect to any choice or conflict of law provision or rule (whether of the State of Florida or any other jurisdiction) that would cause the application of the laws of any jurisdiction other than
the State of Florida. The parties agree that any and all actions arising under or in respect of this Agreement shall be litigated in 

 
any federal or state court of competent jurisdiction located in the County of Duval, State of Florida. By execution and delivery of this Agreement, each
party irrevocably submits to the personal and exclusive jurisdiction of such courts for itself or himself, and in respect of its or his property with respect to such action. Each party agrees that venue would be proper in any of such courts, and
hereby waives any objection that any such court is an improper or inconvenient forum for the resolution of any such action. Executive acknowledges and agrees that he has had the opportunity to seek his own independent legal counsel to represent
Executive’s interest in connection with the transactions contemplated by this Agreement. 
 17. MISCELLANEOUS. 
 (a) The section headings contained herein are for reference purposes only and shall not in any way affect the meaning or the interpretation of this
Agreement. 
 (b) The failure of any party to enforce any provision of this Agreement shall in no manner affect the right to enforce the
same, and the waiver by any party of any breach of any provision of this Agreement shall not be construed to be a waiver by such party of any succeeding breach of such provision or a waiver by such party of any breach of any other provision.

 (c) Except as otherwise provided herein, in the event any one or more of the provisions of this Agreement shall for any reason be held
invalid, illegal or unenforceable, the remaining provisions of this Agreement shall be unimpaired, and the invalid, illegal or unenforceable provision shall be replaced by a mutually acceptable valid, and enforceable provision which comes closest to
the intent of the parties. 
 (d) The prevailing party in any litigation brought to enforce the provisions of this Agreement shall be
entitled to reimbursement from the nonprevailing party for reasonable attorney’s fees and costs incurred in connection with such litigation. 
 (e) This Agreement may be executed in any number of counterparts, each of which shall constitute an original and all of which together shall constitute one and the same instrument. 
 (f) This Agreement is being entered into among competent and experienced parties represented by counsel, has been reviewed by the parties and counsel for
each of Executive and the Company, and therefore any ambiguous language in this Agreement shall not be construed against either party as the drafter of this Agreement. 
 [Signatures Appear on Following Page] 

 IN WITNESS WHEREOF, the parties have executed this Employment Agreement as of the day and year first
above written. 
  

			
	MSC-MEDICAL SERVICES COMPANY, a Florida corporation
		
	By:	 	 /s/ Joseph P. Delaney

	Name:	 	Joseph P. Delaney
	Title:	 	Chief Executive Officer
	
	EXECUTIVE:
	
	 /s/ Robert DiProva

	Robert DiProva
		
	Address:

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00138-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00138-of-00352.parquet"}]]